2. Academic Validation
  3. Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity

  • Cancer Res. 2016 Mar 1;76(5):1146-1157. doi: 10.1158/0008-5472.CAN-15-0442.
Dong Joon Kim  # 1 2,  Eunmiri Roh  # 1,  Mee-Hyun Lee 1 3,  Naomi Oi 1,  Do Young Lim 1,  Myoung Ok Kim 1 4,  Young-Yeon Cho 5,  Angelo Pugliese 1,  Jung-Hyun Shim 1 6,  Hanyong Chen 1,  Eun Jin Cho 1,  Jong-Eun Kim 1,  Sun Chul Kang 7,  Souren Paul 7,  Hee Eun Kang 5,  Ji Won Jung 5,  Sung-Young Lee 1,  Sung-Hyun Kim 1 4,  Kanamata Reddy 1,  Young Il Yeom 2,  Ann M Bode 1,  Zigang Dong 1
Affiliations

Affiliations

  • 1 The Hormel Institute, University of Minnesota, Austin, MN 55912, USA.
  • 2 Biomedical Genomics Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB), Daejeon, 305-806, Korea.
  • 3 China-US Hormel Institute, Henan, 45008, China.
  • 4 Center for Laboratory Animal Resources, School of Animal Biotechnology, Kyungpook National University, Dae-gu, 700-842, Republic of Korea.
  • 5 Department of Pharmacology, College of Pharmacy, The Catholic University of Korea, Bucheon 420-743, Republic of Korea.
  • 6 College of Pharmacy, Mokpo National University, Muan-gun, Jeonnam 534-729, Republic of Korea.
  • 7 Department of Biotechnology, Daegu University, Kyoungsan, Kyoungbook 712-714, Republic of Korea.
  • # Contributed equally.
PMID: 26676750 DOI: 10.1158/0008-5472.CAN-15-0442
Abstract

Ornithine decarboxylase (ODC) is a rate-limiting Enzyme in the first step of polyamine biosynthesis that is associated with cell growth and tumor formation. Existing catalytic inhibitors of ODC have lacked efficacy in clinical testing or displayed unacceptable toxicity. In this study, we report the identification of an effective and nontoxic allosteric inhibitor of ODC. Using computer docking simulation and an in vitro ODC Enzyme assay, we identified herbacetin, a natural compound found in flax and other Plants, as a novel ODC inhibitor. Mechanistic investigations defined aspartate 44 in ODC as critical for binding. Herbacetin exhibited potent Anticancer activity in colon Cancer cell lines expressing high levels of ODC. Intraperitoneal or oral administration of herbacetin effectively suppressed HCT116 xenograft tumor growth and also reduced the number and size of polyps in a mouse model of APC-driven colon Cancer (ApcMin/+). Unlike the well-established ODC inhibitor DFMO, herbacetin treatment was not associated with hearing loss. Taken together, our findings defined the natural product herbacetin as an allosteric inhibitor of ODC with chemopreventive and antitumor activity in preclinical models of colon Cancer, prompting its further investigation in clinical trials.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z